Dual targeting of wild‐type p53 and gut microbiota by Magnolol represses key metabolic process and kills CRC cells
Phytotherapy Research · 2024
DOI: 10.1002/ptr.7924 ↗At a glance
Journal article in Phytotherapy Research, 2024. Written by Haixia Ji and 7 co-authors. Institution: School of Chemistry and Chemical Engineering, North University of China, Taiyuan, China. Major MEDLINE topics: Lignans, Tumor Suppressor Protein p53, Gastrointestinal Microbiome, Biphenyl Compounds. Cited 4 times so far (Crossref); 46 references.
Abstract (original language)
Cancer cells consume considerable glucose quantities and majorly employ glycolysis for ATP generation. This metabolic signature (the Warburg effect) allows cancer cells to channel glucose to biosynthesis to support and maintain their dramatic growth along with proliferation. Currently, our understanding of the metabolic and mechanistic implications of the Warburg effect along with its relationship with biosynthesis remains unclear. Herein, we illustrate that the tumor repressor p53 mediate Magnolol (MAG) triggers colon cancer cell apoptosis. And MAG regulates the glycolytic and oxidative phosphorylation steps through transcriptional modulation of its downstream genes TP53‐induced glycolysis modulator and biosynthesis of cytochrome c oxidase, attenuating cell proliferation and tumor growth in vivo and in vitro. Meanwhile, we show that MAG cooperates with its own intestinal microflora characteristic metabolites to repress tumors, especially remarkably declined kynurenine (Kyn)/tryptophan (Trp) ratio. Besides, strong relationships of MAG influenced genes, microbiota, as well as metabolites, were explored. Therefore, we established that p53‐microbiota‐metabolites function as a mechanism, which enable therapy approaches against metabolism‐implicated colorectal cancer, in particular MAG as a prospective candidate for treating colorectal cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Chemistry and Chemical Engineering, North University of China, Taiyuan, China.
- School of Chemistry and Chemical Engineering, Tianjin University, Tianjin, China.
ORCID profiles: Haixia Ji
Cite
APA
Ji, H., Qiao, O., Zhang, Y., Wang, W., Han, X., Zhang, X., Liu, C., & Gao, W. (2024). Dual targeting of wild‐type p53 and gut microbiota by Magnolol represses key metabolic process and kills CRC cells. Phytotherapy Research. https://doi.org/10.1002/ptr.7924
Vancouver
Ji H, Qiao O, Zhang Y, Wang W, Han X, Zhang X, et al. Dual targeting of wild‐type p53 and gut microbiota by Magnolol represses key metabolic process and kills CRC cells. Phytotherapy Research. 2024. doi:10.1002/ptr.7924
BibTeX
@article{Ji2024,
author = {Ji, Haixia and Qiao, Ou and Zhang, Yi and Wang, Wenzhe and Han, Xiaoyin and Zhang, Xinyu and Liu, Changxiao and Gao, Wenyuan},
title = {Dual targeting of wild‐type p53 and gut microbiota by Magnolol represses key metabolic process and kills CRC cells},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.7924}
}
EUVIMED